Journal article icon

Journal article

Cytokine profiles amongst Sudanese patients with visceral leishmaniasis and malaria co-infections

Abstract:
Background The immune system plays a critical role in the development of co-infections, promoting or preventing establishment of multiple infections and shaping the outcome of pathogen-host interactions. Its ability to mediate the interplay between visceral leishmaniasis (VL) and malaria has been suggested, but poorly documented. The present study investigated whether concomitant infection with Leishmania donovani complex and Plasmodium falciparum in naturally co-infected patients altered the immunological response elicited by the two pathogens individually. Results Circulating levels of interferon (IFN)-γ, interleukin (IL)-2, IL-4, IL-6, IL-10, IL-12p70, IL-13, IL-17A and tumor necrosis factor (TNF) were assessed in sera of patients infected with active VL and/or malaria and healthy individuals from Gedarif State, Sudan. Comparative analysis of cytokine profiles from co- and mono-infected patients highlighted significant differences in the immune response mounted upon co-infection, confirming the ability of L. donovani and P. falciparum to mutually interact at the immunological level. Progressive polarization towards type-1 and pro-inflammatory cytokine patterns characterized the co-infected patients, whose response partly reflected the effect elicited by VL (IFN-γ, TNF) and malaria (IL-2, IL-13), and partly resulted from a synergistic interaction of the two diseases upon each other (IL-17A). Significantly reduced levels of P. falciparum parasitaemia (P <0.01) were detected in the co-infected group as opposed to the malaria-only patients, suggesting either a protective or a non-detrimental effect of the co-infection against P. falciparum infection. Conclusions These findings suggest that a new immunological scenario may occur when L. donovani and P. falciparum co-infect the same patient, with potential implications on the course and resolution of these diseases
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1186/1471-2172-15-16

Authors

More by this author
Role:
Author
ORCID:
0000-0001-6239-4517
More by this author
Role:
Author
ORCID:
0000-0003-1927-352X
More by this author
Role:
Author
ORCID:
0000-0002-5783-8846
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-0816-2835


Publisher:
BioMed Central
Journal:
BMC Immunology More from this journal
Volume:
15
Issue:
1
Pages:
16-16
Publication date:
2014-05-01
DOI:
EISSN:
1471-2172
ISSN:
1471-2172


Language:
English
Keywords:
Pubs id:
2358434
Local pid:
pubs:2358434
Source identifiers:
W1967550453
Deposit date:
2026-01-14
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP